secwatch.observer — SEC 8-K summary
======================================

Issuer:     BICYCLE THERAPEUTICS PLC (BCYC)
CIK:        0001761612
Form:       8-K
Filed at:   2026-08-20T20:05:23+00:00
Accession:  0001104659-26-099221
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Bicycle Therapeutics director Charles Swanton resigns effective immediately
---------------------------------------------------------------------------

- On August 18, 2026, Charles Swanton resigned as Class II director, committee member, and Clinical Advisory Board member.
- Resignation effective immediately; cited personal reasons, no disagreement with company operations.
- Ticker BCYC; resignation disclosed in Form 8-K filed August 20, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1761612/000110465926099221/0001104659-26-099221-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1761612/000110465926099221/tm2623656d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-099221

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer